Keryx Biopharmaceuticals (KERX) +9.3%, although there's no obvious news that's could have triggered the spike. The message boards on Yahoo Finance speculate that the jump could be due to insider buying, while Five Star Equities seems to finger Keryx as a possible acquisition target as Big Pharma looks to replace expiring patents.
Alcoa (AA +2.9%) receives the latest of several warnings on guidance, as Dahlman Rose cuts its Q2 earnings estimates from $0.07/share on $640M in revenue to $0.03/share on revenue of $550M, citing weak aluminum prices. But the firm maintains its Buy rating and $14.65 price target, which suggests 70% upside to the stock’s Monday closing price of $8.63.
Alcoa (AA +2.9%) receives the latest of several warnings on guidance, as Dahlman Rose cuts its Q2 earnings estimates from $0.07/share on $640M in revenue to $0.03/share on revenue of $550M, citing weak aluminum prices. But the firm maintains its Buy rating and $14.65 price target, which suggests 70% upside to the stock’s Monday closing price of $8.63.
More Stocks News
For the latest updates on the stock market, visit,
http://daytradingstock-blog.blogspot.com/
